Non-invasive optical imaging of matrix metalloproteinase activity with albumin-based fluorogenic nanoprobes during angiogenesis in a mouse hindlimb ischemia model.

[1]  G. Opdenakker,et al.  Zymography methods for visualizing hydrolytic enzymes , 2013, Nature Methods.

[2]  M. Rosenblum,et al.  Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles. , 2012, Biomaterials.

[3]  Shahram Hejazi,et al.  Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano Carriers. , 2012, Chemistry of materials : a publication of the American Chemical Society.

[4]  Kwangmeyung Kim,et al.  Measurement of MMP Activity in Synovial Fluid in Cases of Osteoarthritis and Acute Inflammatory Conditions of the Knee Joints Using a Fluorogenic Peptide Probe-Immobilized Diagnostic Kit , 2012, Theranostics.

[5]  Eun Seong Lee,et al.  Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types. , 2012, Biomaterials.

[6]  Kwangmeyung Kim,et al.  Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe. , 2011, Arthritis and rheumatism.

[7]  Erlong Zhang,et al.  A review of NIR dyes in cancer targeting and imaging. , 2011, Biomaterials.

[8]  R. Vandenbroucke,et al.  Matrix metalloproteinases as drug targets in ischemia/reperfusion injury. , 2011, Drug discovery today.

[9]  Ick Chan Kwon,et al.  Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. , 2011, Biomaterials.

[10]  P. Choyke,et al.  Biodistribution and excretion of monosaccharide-albumin conjugates measured with in vivo near-infrared fluorescence imaging. , 2010, Bioconjugate chemistry.

[11]  I. Riemann,et al.  Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles. , 2010, Biomaterials.

[12]  C. Ahn,et al.  Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo. , 2009, Nano letters.

[13]  Hsiao-Ya Tsai,et al.  Matrix Metalloproteinase-9 Is Essential for Ischemia-Induced Neovascularization by Modulating Bone Marrow–Derived Endothelial Progenitor Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Felix Kratz,et al.  Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[15]  A. Sinusas,et al.  Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling , 2008, Circulation.

[16]  H. Kang,et al.  Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha. , 2008, Vaccine.

[17]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[18]  Marcelino Bernardo,et al.  A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. , 2007, Cancer research.

[19]  Shaoqun Zeng,et al.  Detection of MMP activity in living cells by a genetically encoded surface-displayed FRET sensor. , 2007, Biochimica et biophysica acta.

[20]  K. Higaki,et al.  Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition. , 2007, International journal of pharmaceutics.

[21]  Michael Hawkins,et al.  Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  G. Fields,et al.  Development of a solid-phase assay for analysis of matrix metalloproteinase activity. , 2004, Journal of biomolecular techniques : JBT.

[23]  M. Fini,et al.  Matrix Metalloproteinase-9 Is Required for Adequate Angiogenic Revascularization of Ischemic Tissues: Potential Role in Capillary Branching , 2004, Circulation research.

[24]  F. Spinale,et al.  Selective Targeting and Timing of Matrix Metalloproteinase Inhibition in Post-Myocardial Infarction Remodeling , 2003, Circulation.

[25]  G. Plitas,et al.  Temporal expression and activation of matrix metalloproteinases-2, -9, and membrane type 1-matrix metalloproteinase following acute hindlimb ischemia. , 2003, The Journal of surgical research.

[26]  M. Radomski,et al.  Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. , 2000, Circulation.

[27]  M. d’Ortho,et al.  Increased expression of gelatinases and alteration of basement membrane in rat soleus muscle following femoral artery ligation , 2000, Neuropathology and applied neurobiology.

[28]  Timo Sorsa,et al.  Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.

[29]  J. Koziol,et al.  Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  G. Luker,et al.  Targeted non-covalent self-assembled nanoparticles based on human serum albumin. , 2012, Biomaterials.

[31]  P A Narayana,et al.  High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent. , 2007, AJNR. American journal of neuroradiology.